Interleukin 2 in the management of acute leukaemia

被引：20

作者：

Foa, R ^{[1
]}

机构：

[1] UNIV TURIN, CNR, CTR IMMUNOGENET & ONCOL SPERIMENTALE, TURIN, ITALY

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 92卷 / 01期

关键词：

IL2; acute leukaemia; immunotherapy; gene therapy;

D O I：

10.1046/j.1365-2141.1996.270834.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1 / 8

页数：8

共 85 条

[1]

ACKERSTEIN A, 1991, BLOOD, V78, P1212

[2]

ADLER A, 1988, BLOOD, V71, P709

[3] INDUCIBILITY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION AND ITS CLINICAL RELEVANCE [J].

ARCHIMBAUD, E ;

BAILLY, M ;

DORE, JF .

BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) :328-334

[4] CERTAIN MYELOID CELLS POSSESS RECEPTORS FOR INTERLEUKIN-2 [J].

ARMITAGE, RJ ;

LAI, AP ;

ROBERTS, PJ ;

CAWLEY, JC .

BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) :799-807

[5]

BENYUNES MC, 1993, BONE MARROW TRANSPL, V12, P159

[6]

BENYUNES MC, 1995, BONE MARROW TRANSPL, V16, P283

[7] INTERLEUKIN-2 BOLUS INFUSION AS LATE CONSOLIDATION THERAPY IN 2ND REMISSION OF ACUTE MYELOBLASTIC-LEUKEMIA [J].

BERGMANN, L ;

HEIL, G ;

KOLBE, K ;

LENGFELDER, E ;

PUZICHA, E ;

MARTIN, H ;

LOHMEYER, J ;

MITROU, PS ;

HOELZER, D .

LEUKEMIA & LYMPHOMA, 1995, 16 (3-4) :271-279

[8]

BLAISE D, 1990, BLOOD, V76, P1092

[9]

Champlin R E, 1990, Cancer Treat Res, V50, P99

[10]

CHARAK BS, 1991, CANCER RES, V51, P2015

← 1 2 3 4 5 6 7 8 9 →